Volker Rudolph

ORCID: 0000-0001-5385-6839
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Valve Diseases and Treatments
  • Cardiovascular Function and Risk Factors
  • Infective Endocarditis Diagnosis and Management
  • Cardiac Structural Anomalies and Repair
  • Cardiac pacing and defibrillation studies
  • Cardiac Imaging and Diagnostics
  • Neutrophil, Myeloperoxidase and Oxidative Mechanisms
  • Pulmonary Hypertension Research and Treatments
  • Nitric Oxide and Endothelin Effects
  • Cardiac Arrhythmias and Treatments
  • Aortic Disease and Treatment Approaches
  • Acute Myocardial Infarction Research
  • Atrial Fibrillation Management and Outcomes
  • Cardiac Fibrosis and Remodeling
  • Mechanical Circulatory Support Devices
  • Eicosanoids and Hypertension Pharmacology
  • Cardiac Ischemia and Reperfusion
  • Congenital Heart Disease Studies
  • Cardiomyopathy and Myosin Studies
  • Heart Failure Treatment and Management
  • Coronary Interventions and Diagnostics
  • Cardiac and Coronary Surgery Techniques
  • Adipose Tissue and Metabolism
  • Cardiac, Anesthesia and Surgical Outcomes
  • Atherosclerosis and Cardiovascular Diseases

Ruhr University Bochum
2020-2025

Heart and Diabetes Center North Rhine-Westphalia
2019-2025

Bielefeld University
2024-2025

University Hospitals of the Ruhr-University of Bochum
2022-2025

University of Cologne
2013-2024

University Hospital Cologne
2012-2024

Friedrich Schiller University Jena
2024

Jena University Hospital
2003-2024

LWL-Universitätsklinikum Bochum
2022-2024

Northwestern University
2023

Recruitment and activation of polymorphonuclear neutrophils (PMNs) reflects a primary immunological response to invading pathogens has also emerged as hallmark vascular inflammation. One the principal enzymes released upon PMN is myeloperoxidase (MPO), heme protein that not only generates cytotoxic oxidants but impacts deleteriously on nitric oxide-dependent signaling cascades within vasculature. Because MPO associates with membrane PMN, we evaluated whether could function an autocrine...

10.1073/pnas.0405193102 article EN Proceedings of the National Academy of Sciences 2004-12-29

Background: Current surgical and medical treatment options for severe tricuspid regurgitation (TR) are limited, additional interventional approaches required. In the present observational study, safety feasibility of transcatheter repair chronic TR with MitraClip system were evaluated. addition, effects on clinical symptoms assessed. Methods: Patients heart failure optimal treated system. Safety, defined as periprocedural adverse events such death, myocardial infarction, stroke, or cardiac...

10.1161/circulationaha.116.024848 article EN Circulation 2017-03-24

We sought to assess the feasibility of catheter-based mitral valve repair using MitraClip system in high-surgical-risk patients with regurgitation (MR) ≥grade 3+. therapy was performed 51 consecutive [73 ± 10 years; 34 (67%) men] symptomatic functional [n = 35 (69%)] or organic MR 16 (31%)]. Mean logistic EuroSCORE 29 22%; Society Thoracic Surgeons score 15 11. Left ventricular (LV) ejection fraction 36 17%. In (69%), adverse morphology and/or severe LV dysfunction were present. implantation...

10.1093/eurheartj/ehq050 article EN European Heart Journal 2010-03-10

The role of catheter ablation in patients with symptomatic atrial fibrillation and end-stage heart failure is unknown. Download a PDF the Research Summary. We conducted single-center, open-label trial Germany that involved who were referred for transplantation evaluation. Patients assigned to receive guideline-directed medical therapy or alone. primary end point was composite death from any cause, implantation left ventricular assist device, urgent transplantation. A total 97 group...

10.1056/nejmoa2306037 article EN New England Journal of Medicine 2023-08-27

Secondary (or functional) mitral regurgitation (SMR) occurs frequently in chronic heart failure (HF) with reduced left ventricular (LV) ejection fraction, resulting from LV remodelling that prevents coaptation of the valve leaflets. contributes to progression symptoms and signs HF confers worse prognosis. The management patients SMR is complex requires timely referral a multidisciplinary Heart Team. Optimization pharmacological device therapy according guideline recommendations crucial....

10.1093/eurheartj/ehab086 article EN cc-by-nc European Heart Journal 2021-02-21

Severe tricuspid regurgitation (TR) is known to be associated with substantial morbidity and mortality.The authors sought study the acute outcomes of subjects treated by transcatheter edge-to-edge repair TriClip system (Abbott) in a contemporary, real-world setting.The bRIGHT (An Observational Real-World Study Evaluating Tricuspid Regurgitation Patients Treated With Abbott TriClip™ Device) postapproval prospective, single-arm, open-label, multicenter, postmarket registry conducted at 26...

10.1016/j.jacc.2023.05.008 article EN cc-by-nc-nd Journal of the American College of Cardiology 2023-05-17
Julien Dreyfus Xavier Galloo Maurizio Taramasso Gregor Heitzinger Giovanni Benfari and 95 more Karl-Patrick Kresoja Fernando M. Juarez-Casso Hazem Omran Yohann Bohbot Christos Iliadis Giulio Russo Yan Topilsky Marcel Weber Luis Nombela‐Franco Alessandra Sala Andrea Eixerés‐Esteve Bernard Iung Jean‐François Obadia Rodrigo Estévez‐Loureiro Elisabeth Riant Erwan Donal Jörg Hausleiter Luigi P. Badano Thierry Le Tourneau Augustin Coisne Thomas Modine Azeem Latib Fabien Praz Stephan Windecker José Luis Zamorano Ralph Stephan von Bardeleben Gilbert H.L. Tang Rebecca T. Hahn John G. Webb Denisa Muraru Mohammed Nejjari Vincent Chan Michele De Bonis Manuel Carnero Georg Nickenig Roman Pfister Christophe Tribouilloy Volker Rudolph Juan A. Crestanello Philipp Lurz Philipp E. Bartko Francesco Maisano Jeroen J. Bax Maurice Enriquez‐Sarano David Messika‐Zeitoun Julien Dreyfus Xavier Galloo Maurizio Taramasso Gregor Heitzinger Giovanni Benfari Karl-Patrick Kresoja Fernando M. Juarez-Casso Hazem Omran Yohan Bohbot Christos Iliadis Giulio Russo Yan Topilsky Marcel Weber Luis Nombela‐Franco Alessandra Sala Andrea Eixerés‐Esteve Bernard Iung Jean‐François Obadia Rodrigo Estévez‐Loureiro Elisabeth Riant Pascal Lim Baptiste Bazire Erwan Donal Jörg Hausleiter Luigi P. Badano Thierry Le Tourneau Augustin Coisne Thomas Modine Yoan Lavie‐Badie Fabien Doguet Gilbert Habib Christine Selton‐Suty N Ajmone-Marsan Azeem Latib Lukas Stolz Fabien Praz Stephan Windecker José Luís Zamorano Ralph Stephan von Bardeleben T. Ruf Gilbert H.L. Tang Rebecca T. Hahn Edith Lubos John A. Webb Joachim Schöfer Neil Fam Alexander Lauten Giovanni Pedrazzini Josep Rodés‐Cabau Denisa Muraru

Abstract Background and aims Benefit of tricuspid regurgitation (TR) correction timing intervention are unclear. This study aimed to compare survival rates after surgical or transcatheter conservative management according a TR clinical stage as assessed using the TRI-SCORE. Methods A total 2,413 patients with severe isolated functional were enrolled in TRIGISTRY (1217 conservatively managed, 551 valve surgery, 645 repair). The primary endpoint was at 2 years. Results TRI-SCORE low (≤3) 32%,...

10.1093/eurheartj/ehad585 article EN European Heart Journal 2023-08-25

BackgroundCurrent treatment recommendations for patients with heart failure and secondary mitral regurgitation include transcatheter edge-to-edge repair mitral-valve surgery. Data from randomized trials comparing these therapies are lacking in this patient population.MethodsIn noninferiority trial conducted Germany, who continued to have symptoms despite guideline-directed medical therapy were randomly assigned, a 1:1 ratio, undergo either (intervention group) or surgical replacement...

10.1056/nejmoa2408739 article EN New England Journal of Medicine 2024-08-31
Julien Dreyfus Maurizio Taramasso Karl‐Patrik Kresoja Hazem Omran Christos Iliadis and 95 more Giulio Russo Marcel Weber Luis Nombela‐Franco Rodrigo Estévez‐Loureiro Jörg Hausleiter Azeem Latib Lukas Stolz Fabien Praz Stephan Windecker José Luís Zamorano Ralph Stephan von Bardeleben Gilbert H.L. Tang Rebecca T. Hahn Edith Lubos John A. Webb Joachim Schöfer Neil Fam Alexander Lauten Giovanni Pedrazzini Josep Rodés‐Cabau Mohammed Nejjari Luigi P. Badano Hannes Alessandrini Dominique Himbert Horst Sievert Kerstin Piayda Erwan Donal Thomas Modine Georg Nickenig Roman Pfister Volker Rudolph Jordan Bernick George A. Wells Jeroen J. Bax Philipp Lurz Maurice Enriquez‐Sarano Francesco Maisano David Messika‐Zeitoun N Ajmone-Marsan Hannes Alessandrini Luigi P. Badano Philipp E. Bartko Jeroen J. Bax Baptiste Bazire Giovanni Benfari Jordan Bernick Yohan Bohbot Manuel Carnero Vincent Chan Augustin Coisne Juan A. Crestanello Michele De Bonis Fabien Doguet Erwan Donal Julien Dreyfus Florian Eggenspieler Maurice Enriquez‐Sarano Andrea Eixerés‐Esteve Rodrigo Estévez‐Loureiro Damien Eyharts Neil Fam Michele Flagiello Xavier Galloo Mara Gavazzoni Gilbert Habib Rebecca T. Hahn Jörg Hausleiter Gregor Heitzinger Dominique Himbert Christos Iliadis Bernard Iung Fernando M. Juarez-Casso Karl-Patrick Kresoja Azeem Latib Alexander Lauten Yoan Lavie‐Badie Thierry Le Tourneau Pascal Lim Edith Lubos Philipp Lurz Francesco Maisano Yannick Mbaki Héctor I. Michelena Thomas Modine David Messika‐Zeitoun Denisa Muraru Mohammed Nejjari Georg Nickenig Martin Nicol Luis Nombela‐Franco Jean‐François Obadia Hazem Omran Giovanni Pedrazzini Roman Pfister Kerstin Piayda

10.1016/j.jcin.2024.04.023 article EN КАРДИОЛОГИЯ УЗБЕКИСТАНА 2024-05-16
Jörg Hausleiter Mark Lachmann Lukas Stolz Francesco Bedogni Antonio Popolo Rubbio and 95 more Rodrigo Estévez‐Loureiro Sergio Raposeiras‐Roubín Peter Boekstegers Nicole Karam Volker Rudolph Thomas J. Stocker Mathias Orban Daniel Braun Michael Näbauer Steffen Maßberg Aniela Popescu T. Ruf Ralph Stephan von Bardeleben Christos Iliadis Roman Pfister Stephan Baldus Christian Besler Tobias Kister Karl Patrik Kresoja Philipp Lurz Hölger Thiele Benedikt Koell Niklas Schofer Daniel Kalbacher Michael Neuß Christian Butter Karl‐Ludwig Laugwitz Teresa Trenkwalder Eroion Xhepa Michael Joner Hazem Omran Vera Fortmeier Muhammed Gerçek Harald Beucher Thomas Schmitz Alexander Bufe Jürgen Rothe Melchior Seyfarth Tobias Schmidt Christian Frerker Dennis Rottländer Patrick Horn Maximilian Spieker Elric Zweck Mohammad Kassar Fabien Praz Stephan Windecker Tania Puscas Marianna Adamo L Lupi Marco Metra Emmanuel Villa Giuseppe Biondi‐Zoccai Corrado Tamburino Carmelo Grasso Fausto Catriota Luca Testa Maurizio Tusa Cosmo Godino Michele Galasso Matteo Montorfano Eustachio Agricola Paolo Denti Federico De Marco Giuseppe Tarantini Giulia Masiero Gabriele Crimi Andrea Munafò Christina Giannini Anna Sonia Petronio Stefano Pidello Paolo Boretto Antonio Montefusco Simone Frea Filippo Angelini Pier Paolo Bocchino Francesco De Felice Rodolfo Citro Berenice Caneiro‐Queija Xavier Freixa Ander Regueiro Laura Sanchís Manel Sabaté Dabit Arzamendi Lluís Asmarats Estefanía Fernández‐Peregrina Tomas Benito‐González Felipe Fernández‐Vázquez Isaac Pascual Pablo Avanzas Luis Nombela‐Franco Gabriela Tirado‐Conte Eduardo Pozo A Portoles Vanessa Moñivas Palomero

Abstract Background and Aims Risk stratification for mitral valve transcatheter edge-to-edge repair (M-TEER) is paramount in the decision-making process to appropriately select patients with severe secondary regurgitation (SMR). This study sought develop validate an artificial intelligence-derived risk score (EuroSMR score) predict 1-year outcomes (survival or survival + clinical improvement) SMR undergoing M-TEER. Methods An was developed from EuroSMR cohort (4172 428 treated M-TEER...

10.1093/eurheartj/ehad871 article EN European Heart Journal 2024-01-19

Aims Data on the prognostic impact of residual tricuspid regurgitation (TR) after transcatheter edge‐to‐edge repair (T‐TEER) are scarce. The aim this analysis was to evaluate 2‐year survival and symptomatic outcomes patients in relation TR T‐TEER. Methods results Using large European Registry Transcatheter Repair for Tricuspid Regurgitation (EuroTR registry) we investigated all‐cause mortality New York Heart Association (NYHA) functional class at follow‐up. study further identified...

10.1002/ejhf.3274 article EN cc-by-nc European Journal of Heart Failure 2024-05-29

Neutrophils and monocytes are centrally linked to vascular inflammatory disease, leukocyte-derived myeloperoxidase (MPO) has emerged as an important mechanistic participant in impaired vasomotor function. MPO binds transcytoses endothelial cells a glycosaminoglycan-dependent manner, binding the vessel wall is prerequisite for MPO-dependent oxidation of endothelium-derived nitric oxide (NO) impairment function animal models. In present study, we investigated whether heparin mobilizes from...

10.1161/circulationaha.105.590083 article EN Circulation 2006-04-11

AimsNitrated fatty acids (NO 2 -FA) have been identified as endogenous anti-inflammatory signalling mediators generated by oxidative inflammatory reactions.Herein the in vivo generation of nitro-oleic acid (OA-NO ) and nitro-linoleic (LNO was measured a murine model myocardial ischaemia reperfusion (I/R) effect exogenous administration OA-NO on I/R injury evaluated. Methods resultsIn C57/BL6 mice subjected to 30 min coronary artery ligation, LNO formation observed after reperfusion, whereas...

10.1093/cvr/cvp275 article EN Cardiovascular Research 2009-08-07

The peroxisome proliferator-activated receptor-gamma (PPARgamma) binds diverse ligands to transcriptionally regulate metabolism and inflammation. Activators of PPARgamma include lipids anti-hyperglycemic drugs such as thiazolidinediones (TZDs). Recently, TZDs have raised concern after being linked with increased risk peripheral edema, weight gain, adverse cardiovascular events. Most reported endogenous are intermediates lipid oxidation that bind very low affinity. In contrast, nitro...

10.1074/jbc.m109.091512 article EN cc-by Journal of Biological Chemistry 2010-01-23

Background— Surgical aortic valve replacement in patients with small annular dimensions is challenging because they are at increased risk for prosthesis–patient mismatch and impaired outcomes. Transcatheter might be a good alternative; however, comparative data on different transcatheter heart valves missing. Methods Results— This multicenter, propensity score–matched study compared hemodynamics early clinical outcomes 246 an annulus area <400 mm 2 undergoing either self-expanding...

10.1161/circinterventions.117.005013 article EN Circulation Cardiovascular Interventions 2017-09-27
Coming Soon ...